SCHEMBL8865384

SCHEMBL8865384

CCCCCCNCC(=O)OCC

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.51
GAA P10253 2/20 0.50
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
EPHX1 P07099 6/20 0.46
ALDH1A1 P00352 2/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 1/20 0.45
TSHR P16473 1/20 0.44
FAAH O00519 1/20 0.43
S1PR2 O95136 5/20 0.43
S1PR4 O95977 5/20 0.43
S1PR1 P21453 5/20 0.43
S1PR3 Q99500 5/20 0.43
S1PR5 Q9H228 1/20 0.43
NAAA Q02083 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22689618 1.00 LTA4H (0.51) LTA4HGAAMGAMSIMGAM2
SCHEMBL28210814 1.00 LTA4H (0.51) LTA4HGAAMGAMSIMGAM2
SCHEMBL1392816 1.00 LTA4H (0.51) LTA4HGAAMGAMSIMGAM2
SCHEMBL6037465 1.00 LTA4H (0.51) LTA4HGAAMGAMSIMGAM2
Water SCHEMBL8464737 0.98 LTA4H (0.50) LTA4HGAAMGAMSIMGAM2
Hydrochloric Acid SCHEMBL9054794 0.98 LTA4H (0.50) LTA4HGAAMGAMSIMGAM2
SCHEMBL285776 0.98 LTA4H (0.50) LTA4HGAAMGAMSIMGAM2
Hydrochloric Acid SCHEMBL27784732 0.96 LTA4H (0.49) LTA4HGAAMGAMSIMGAM2
SCHEMBL6074966 0.92 GAA (0.50) LTA4HGAAMGAMSIMGAM2
Bromide SCHEMBL29061339 0.90 GAA (0.48) LTA4HGAAMGAMSIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110023294-B Solvent-free ionic liquid epoxy resin 代表亚利桑那大学的亚利桑那校董会 2024-05-24 CN disclosed
WO-2018128720-A1 URACIL CONTAINING COMPOUNDS CV6 THERAPEUTICS (NI) LIMITED (GB) 2018-07-12 WO disclosed
WO-2018098204-A1 6-MEMBERED URACIL ISOSTERES CV6 THERAPEUTICS (NI) LIMITED (GB) 2018-05-31 WO disclosed
WO-2018098206-A1 HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CV6 THERAPEUTICS (NI) LIMITED (GB) 2018-05-31 WO disclosed
US-7687600-B2 Invertible amphiphilic polymers UNIVERSITY OF MASSACHUSETTS (US) 2010-03-30 US disclosed
US-7687600-B2 Invertible amphiphilic polymers UNIVERSITY OF MASSACHUSETTS (US) 2010-03-30 US disclosed
US-20070293669-A1 Invertible amphiphilic polymers UNIVERSITY OF MASSACHUSETTS 2007-12-20 US disclosed
US-20070293669-A1 Invertible amphiphilic polymers UNIVERSITY OF MASSACHUSETTS 2007-12-20 US disclosed
CN-1054376-C Substituted 1H-imidazoles UCB SA (BE) 2000-07-12 CN disclosed
US-5658938-A HYPOTENSIVE AGENT, ANTIISCHMIC AGENTS U C B S.A. (BE) 1997-08-19 US disclosed
CN-1133837-A Substituted 1H-imidazoles UCB SA (BE) 1996-10-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293669-A1 Invertible amphiphilic polymers PHOSPHO1, INF2, AQP1 LTA4H 2472/4885GAA 1964/4885MGAM 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.